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Deficiency of COX-1 causes natriuresis and enhanced sensitiv- The cyclo-oxygenase (COX) pathway for arachidonic
ity to ACE inhibition. acid metabolism produces prostaglandins and thrombox-
Background. Prostanoid products of the cyclo-oxygenase anes [1]. These lipid mediators have a range of biological(COX) pathway of arachidonic acid metabolism modulate blood
actions that are relevant to blood pressure homeostasispressure (BP) and sodium homeostasis. Conventional non-ste-
including regulation of vascular tone [2] and modulationroidal anti-inflammatory drugs (NSAIDs), which inhibit both
COX isoforms (COX-1 and -2), cause sodium retention, exac- of sodium excretion [3, 4]. Two COX isoforms share
erbate hypertension, and interfere with the efficacy of certain similar enzymatic properties but differ markedly in their
anti-hypertensive agents such as angiotensin-converting en-
pattern and regulation of expression [5]: COX-1 is consti-zyme (ACE) inhibitors. While a new class of NSAIDs that spe-
tutively expressed in most tissues whereas the expressioncifically inhibit COX-2 is now widely used, the relative contri-
bution of the individual COX isoforms to these untoward ef- of COX-2 is regulated and can be induced to high levels
fects is not clear. by cytokines and growth factors [6]. While actions of
Methods. To address this question, we studied mice with cyclo-oxygenase metabolites to influence blood pressuretargeted disruption of the COX-1 (Ptgs1) gene. Blood pressure,
have been documented [3], the individual roles of therenin mRNA expression, and aldosterone were measured while
COX isoenzymes in physiological regulation of blooddietary sodium was varied. To study interactions with the renin-
angiotensin system, ACE inhibitors were administered and mice pressure have not been clearly defined.
with combined deficiency of COX-1 and the angiotensin II Some of the evidence supporting a role for the COX
subtype 1A (AT1A) receptor were generated. pathway in regulating blood pressure and kidney func-Results. On a regular diet, BP in COX-1/ mice was near
tion has come from clinical experiences with non-steroi-normal. However, during low salt feeding, BP values were
reduced in COX-1/ compared to / animals, and this dal anti-inflammatory drugs (NSAIDs). The pharmaco-
reduction in BP was associated with abnormal natriuresis de- logical mechanism of action of NSAIDs is based on their
spite appropriate stimulation of renin and aldosterone. Com- inhibition of COX isoforms [5] and conventional NSAIDs
pared to COX-1/mice, the actions of ACE inhibition were
inhibit both COX-1 and COX-2 [5, 7]. In susceptiblemarkedly accentuated in COX-1/ mice. Sodium sensitivity
patients, COX inhibition by NSAIDs may cause acuteand BP lowering also were enhanced in mice with combined
deficiency of COX-1 and AT1A receptor. renal failure, edema, and hypertension [8, 9]. In addition,
Conclusions. The absence of COX-1 is associated with so- NSAIDs may cause resistance to certain antihyperten-
dium loss and enhanced sensitivity to ACE inhibition, sug- sive therapies, especially angiotensin-converting enzymegesting that COX-1 inhibition does not cause hypertension and
(ACE) inhibitors [10, 11]. However, the relative contri-abnormal sodium handling associated with NSAID use.
butions of COX-1 and COX-2 inhibition to these adverse
effects of NSAIDs are not clear. Recently, NSAIDs with
specificity for COX-2 have been introduced for clinical
use. These agents appear to have analgesic actions that
are equivalent to conventional NSAIDs, but they cause
fewer gastrointestinal toxicities. However, there is someKey words: prostaglandins, mouse, gene targeting, renin, angiotensin II,
NSAIDs, antihypertension, analgesics. lack of consensus in clinical studies regarding the effects
of COX-2 inhibitors on blood pressure regulation andReceived for publication May 30, 2001
responses to antihypertensive therapy. Moreover, the roleand in revised form July 24, 2001
Accepted for publication July 26, 2001 of COX-1 in blood pressure homeostasis is unknown.
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pressure, a mouse cell line with targeted disruption of transcribed in vitro. Renin mRNA levels were expressed
as pg of renin mRNA/g total kidney RNA.the COX-1 (Ptgs1) gene was used [12]. Our current study
documents actions of COX-1 to maintain blood pressure
Effects of reduced dietary sodium on systolicand sodium balance and suggests that inhibition of
blood pressuresCOX-1 would have favorable effects in hypertension.
To determine the effects of the COX-1 gene disruption
on the adaptation to a reduced dietary sodium intake,
METHODS systolic blood pressures were measured in mice that were
sequentially fed diets differing in sodium chloride con-Mice
tent. COX-1/(N 8) and COX-1/ (N 12) miceThe generation of COX-1 and angiotensin II subtype
were first fed a control diet containing 0.4% sodium1A (AT1A) receptor-deficient mice has been described
chloride for 14 days. This was followed by a 14-day periodpreviously [12, 13]. The COX-1-deficient mice were bred
in which the animals were fed a low salt diet containingto the AT1A receptor-deficient strain to generate double
0.02% sodium chloride. Diets were purchased frommutant COX-1 and AT1A animals. Mice were screened Harlan-Teklad (Madison, WI, USA). Mice were allowedfor the appropriate targeted gene mutations by Southern
free access to water. Systolic blood pressures were mea-
blot or polymerase chain reaction (PCR) analysis of tail sured at least five times per week throughout the period
genomic DNA as previously described [12, 13]. Animals of study.
were bred and maintained in the animal facility of the
Durham VAMC under National Institutes of Health Measurements of urinary sodium and
(Bethesda, MD, USA) guidelines. aldosterone excretion
To estimate urinary excretion of sodium and aldoste-
Systolic blood pressure measurements in rone, mice were individually housed in specially designed
conscious mice metabolic cages that accommodate individual mice [17].
Systolic blood pressures were measured in conscious Separate groups of COX-1/ (N  7) and / (N 
mice using a computerized tail cuff system (Visitech Sys- 6) mice were fed a normal salt (0.4% NaCl) diet followed
tems, Cary, NC, USA) that determines systolic blood by a low salt (0.02% NaCl) diet. Twenty-four-hour
pressure using a photoelectric sensor [14]. This system urine specimens were collected and urine sodium was
allows pressures to be measured in four mice simultane- measured with a flame photometer (Instrumentation
Laboratory, Lexington, MA, USA). The 24-hour urineously and minimizes the potential for observer bias. Be-
sample on day 7 of each diet period was collected andfore the study was initiated, mice were adapted to the
aldosterone concentration was measured by radioimmu-apparatus for at least five days. The validity of this system
noassay according to the manufacturer’s instructionshas been established previously [14] and we have demon-
(Diagnostic Labs, Los Angeles, CA, USA).strated its correlation with intra-arterial pressure mea-
surements in several experimental systems [13, 14].
Effects of ACE inhibition in COX-1-deficient mice
To examine the effect of reducing angiotensin II levelsRenin mRNA expression in mouse kidneys
on blood pressure, COX-1/ (N  10) and / miceTo examine the effects of the COX-1 mutation on the
(N  8) were treated with enalapril 30 mg/kg/day byactivity of the renin-angiotensin system (RAS), renin
gavage for 14 days. Systolic blood pressures were mea-mRNA expression was analyzed in kidney cortex from
sured during treatment.wild-type (N 17) and COX-1/mice (N 16) using
a ribonuclease protection assay as described previously Statistical analysis
[15]. Kidneys were harvested, rapidly frozen in liquid The values for each parameter within a group are ex-
nitrogen, and total RNA was isolated using the guanidi- pressed as the mean standard error of the mean (SEM).
nium/isothiocyanate method. Riboprobes labeled with For comparisons between groups, statistical significance
32P were transcribed from a 290 bp fragment from exon 9 was assessed using an unpaired t test. A paired t test was
of the mouse renin gene [16]. The riboprobe was hybrid- used for comparisons within groups. Survival analysis
ized in solution with total RNA from the kidney speci- during low salt feeding was determined by chi-square.
mens. Following RNase treatment, the protected frag-
ments were precipitated with trichloroacetic acid (TCA),
RESULTSfiltered through a glass filter, and 32P cpm was determined
Cyclo-oxygenase-1–deficient mice have normal bloodwith a scintillation counter. To estimate the concentra-
pressures and stimulated renin expressiontion of renin mRNA in each sample, a standard curve was
constructed by hybridizing the 32P-labeled renin probe To determine the effects of COX-1 deficiency on basal
blood pressure regulation, systolic blood pressures in wild-with known quantities of renin cDNA that had been
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Fig. 1. (A) Renin mRNA expression in renal
cortex. Renin mRNA expression levels were
significantly higher in COX-1 deficient mice
compared to wild type controls. During low
salt feeding, renin expression tended to be
higher in COX-1 deficient mice, though this
difference did not achieve statistical signifi-
cance (P  0.37). Data are presented as the
mean  SEM (pg/g of total RNA). Dietary
periods: 0.4% NaCl normal salt (NS);0.02%
NaCl low salt (LS). *P  0.01 vs. wild type
controls; **P  0.01 vs. NS. (B) Effect of
dietary sodium intake on urinary aldosterone
excretion measured in 24-hour urine collec-
tion from wild-type mice and COX-1 deficient
mice. Urinary aldosterone excretion tended
to be higher in COX-1 deficient mice than
wild-type mice on normal diet and low salt diet
but this difference did not achieve statistical
significance. Urinary aldosterone excretion in-
creased significantly during low salt feeding
in both groups. Data are presented as the
mean  SEM (ng/day). P  0.001 vs NS;
P  0.03 vs. NS. Symbols are: () wild-
type controls; () COX-1 deficient mice.
type and COX-1/mice on a conventional (0.4% NaCl) followed a similar pattern (Fig. 1). Aldosterone excretion
increased significantly in both groups during low saltdiet were compared. On this dietary regimen, systolic
blood pressures tended to be lower in COX-1-deficient feeding (P  0.001 vs. baseline for COX-1/ and P 
0.03 versus baseline for COX-1/) and tended to bemice (96  2 mm Hg) than control animals (102  3
mm Hg; P 0.13), but this difference was not statistically higher in the COX-1/ animals (176  51 ng/day)
compared to wild-type controls (86  16 ng/day; P significant. Under similar conditions, renin mRNA ex-
pression in renal cortex was also compared in COX-1 0.14). Upon institution of the low salt diet, urine sodium
excretion fell dramatically in both groups. However,/and/ animals. As shown in Figure 1, renin mRNA
expression was significantly higher in the COX-1-defi- urine sodium excretion was higher in COX-1/ ani-
mals than controls. For example, on day 3 during thecient animals (74  9 pg/g total RNA) than controls
(40 6 pg/g total RNA; P 0.01). Urinary aldosterone adaptation period to the new diet, urine sodium excre-
tion was threefold higher in the COX-1-deficient miceexcretion also tended to be higher in COX-1/ (26 
5 ng/day) than in wild-type animals (20  4 ng/day), (30  12 mEq/day) than controls (10  4 mEq/day; P 
0.05), despite similar food intake.but this difference did not achieve statistical significance
(P  0.35).
Blood pressure response to ACE inhibition is
exaggerated in COX-1-derficient miceCyclo-oxygenase-1 contributes to maintenance of
blood pressure during low salt feeding In view of the enhanced renin expression in COX-1-
deficient mice and reports suggesting that conventionalBased on our findings that the absence of COX-1 is
associated with stimulation of the RAS, we posited that NSAIDs interfere with the actions of ACE inhibitors,
blood pressure responses to ACE inhibition were com-COX-1 might have a role in regulating sodium homeosta-
sis. To examine this possibility, we compared blood pres- pared in COX-1/ and / animals fed the control
(0.4% NaCl) diet. Mice were treated with enalaprilsure and RAS activity in wild-type and COX-1-deficient
animals during dietary sodium depletion. As shown in 30 mg/kg/day by gavage for 14 days and systolic blood
pressures were measured. The ACE inhibitor reducedFigure 3, after 14 days on a diet that is very low in sodium
(0.02% NaCl), blood pressures were significantly lower blood pressures in both groups. However, the hypoten-
sive effects of ACE inhibition were much more markedin COX-1-deficient mice (93  2 mm Hg) than in wild-
type controls (101 3 mm Hg; P 0.04). Figure 1 shows in the COX-1-deficient animals than controls. Following
enalapril treatment, systolic blood pressures were mark-that during low salt feeding, renin mRNA expression in
the renal cortex increased substantially in both groups edly lower in COX-1/ mice (71  3 mm Hg) than
controls (85  3 mm Hg; P  0.01; Fig. 2). These dataand tended to be higher in the COX-1/ mice (125 
10 pg/g total RNA) than controls (106  13 pg/g suggest that the stimulated renin expression in the
COX-1 deficient animals is a compensatory response tototal RNA), but this difference did not achieve statistical
significance (P  0.37); urinary aldosterone excretion maintain blood pressure near normal levels.
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Fig. 3. Influence of low salt feeding on blood pressure. Blood pressures
were lower in COX-1 deficient mice (Ptgs1/) compared to wild-
Fig. 2. Blood pressure response to angiotensin-converting enzyme type controls during low salt feeding. AT1A receptor-deficient mice
(ACE) inhibition. Systolic blood pressures were markedly lower in (Agtr1a/) also had a decrease in blood pressures while on the low
COX-1 deficient mice treated with enalapril () than wild-type controls salt diet. Blood pressures values were further reduced in mice with
(). Data are presented as mean  SEM (mm Hg). *P  0.01 vs wild combined deficiency in both COX-1 and AT1A receptor (Ptgs1/
type controls. Agtr1a/). In addition, 25% of Ptgs1/Agtr1a/mice died during
low salt feeding. Data are presented as mean  SEM (mm Hg). *P 
0.04 vs. wild type controls; **P  0.001 vs. wild-type controls, #P 
0.02 vs. Agtr1a/; †P  0.03 survival during low salt feeding vs.
Ptgs1/.
Mice with combined deficiency of COX-1 and AT1A
angiotensin receptors are markedly sensitive to
sodium depletion
mane to blood pressure and sodium homeostasis [2, 18].To further examine the interactions of the COX-1
For example, prostaglandin (PG) E2 and prostacyclinpathway with the RAS and the mechanism of the exag-
(PGI2) are vasodilators, while thromboxane (TX) A2 isgerated effect of ACE inhibition in COX-1 deficient
a potent vasoconstrictor [18]. Although effects of prosta-mice, we produced mice with combined deficiency of
noids upon vascular tone may acutely alter blood pres-COX-1 and the AT1A angiotensin receptor, the major
sure or regional perfusion, regulation of sodium excretionmurine AT1 receptor isoform. As we have previously
by the kidney is the critical determinant of long-termreported [13], blood pressures are significantly reduced
blood pressure homeostasis [19]. In this regard, COXin mice lacking AT1A receptors (91  3 mm Hg; P 
metabolites also influence kidney functions by modulat-0.02 vs. wild-type). Blood pressures were significantly
ing glomerular filtration rate, renal blood flow, and excre-lower in the COX-1 and AT1A double knockout animals
tion of salt and water [4].(84  3 mm Hg; P  0.001 versus COX-1/ alone).
Both COX isoforms are expressed in the kidney. Prom-Following low salt feeding, blood pressures fell in the
inent expression of COX-1 has been reported in glomer-AT1A receptor-deficient animals (70  3 mm Hg; P 
ular mesangial cells [20] and cortical collecting segments0.001 vs. control diet). The double knockout animals
[20, 21] while COX-2 is expressed in cortical thick as-experienced an even more marked fall in blood pressure
cending limb of the loop of Henle [20, 22] and in the mac-on the low salt diet (61  3 mm Hg; P  0.001 vs.
ula densa [20, 23]. As in other tissues, COX-1 expressionCOX-1/, P  0.02 vs. AT1A receptor-deficient mice;
in the kidney is largely constitutive [6, 20, 21]. On theFig. 3). Moreover, during the period of low salt feeding,
other hand, COX-2 expression is markedly up-regulated25% of the double knockout animals developed marked
by dietary sodium depletion [20, 23, 24]. In the maculareductions in blood pressure, became lethargic and died.
densa, COX2 regulates renin release in chronic sodiumThere were no deaths in any of the other experimental
depletion [23, 25, 26]. COX-2 also may be involved ingroups during low salt feeding (P  0.03 by chi-square
the short loop feedback response whereby angiotensinvs. COX-1/).
II regulates renin release [26]. By contrast, in our studies
there was no indication of a significant role for COX-1
DISCUSSION to regulate renin expression during sodium depletion.
In a conventional environment, COX-1-deficient miceMetabolites produced from arachidonic acid by the
COX pathway mediate diverse physiological processes have a relatively mild phenotype that includes impaired
platelet aggregation and reduced fertility [12]. Unlikeincluding pain, fever, inflammation, and thrombosis [1]. In
addition, biological actions of COX metabolites are ger- COX-2-deficient mice [27, 28], kidney structure and mor-
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phology is normal in COX-1/ animals [12]. When they Prostanoids mediate their biological effects by activat-
ing G protein-coupled receptors [18]. Several classes ofare maintained on standard 0.4% NaCl chow, we find that
blood pressures of COX-1/ mice are slightly lower prostanoid receptors are expressed in the kidney and these
receptors have been linked to epithelial and hemodynamicalthough not significantly different from controls. How-
ever, despite their normal blood pressure, renin expres- functions. EP (E prostanoid) receptors for PGE2 are ex-
pressed on epithelia in proximal and distal nephron seg-sion is significantly increased in kidneys of COX-1-defi-
cient animals. This activation of the RAS seems to have ments [33–35]. In the kidney, stimulation of EP receptors
modulates sodium and water flux [4]. Similarly, throm-functional significance, since the hypotensive response
to ACE inhibition is significantly augmented in sodium- boxane (TP) receptors are expressed in the distal neph-
ron [36] and these receptors stimulate tubuloglomerularreplete COX-1/ mice compared to controls. Thus,
the absence of COX-1 promotes a fall in blood pressure. feedback responses [37, 38]. The specific receptors that
mediate the actions of COX-1 to alter blood pressureIn COX-1/ mice, the RAS seems to be activated as a
compensatory mechanism to help maintain normal blood regulation cannot be determined from our studies. How-
ever, in previous studies, we have observed reducedpressure. Without this compensatory effect, the blood
pressure lowering actions of COX-1-deficiency might be blood pressures and altered sodium handling in mice
deficient in various EP receptor isoforms. For example,more prominent. Because of its expression in the macula
densa and its role in regulation of renin release, we we find that blood pressure is reduced in EP1- [39] and
EP2-deficient mice [40]. Since PGE2 is one of the majorspeculate that COX-2 may be involved in these compen-
satory actions. While a precise mechanism for these regu- prostanoids produced by the kidney [41], it is possible
that the absence of COX-1 is associated with reducedlatory actions has not been identified, administration of
COX-2 inhibitors to human is associated with a dispro- regional production of PGE2 and consequent lack of
stimulation of EP receptor isoforms, such as EP1 or EP2.portionate reduction in prostacyclin synthesis [29, 30]
and prostacyclin is a potent secretagogue for renin [31]. Interactions between the COX pathway and the renin-
angiotensin system have been long recognized [2]. OurFinally, our findings suggest that the actions of conven-
tional NSAIDs to interfere with the antihypertensive ac- studies have identified a novel, cooperative interplay be-
tions of ACE inhibitors are not due to inhibition of COX-1 tween these two systems to maintain blood pressure dur-
and may, therefore, be related to COX-2 inhibition. ing dietary sodium depletion. We have previously reported
With sodium depletion, a significant difference in blood that the absence of the major murine AT1 angiotensin
pressure is uncovered between the COX-1/ and wild- receptor (AT1A) is associated with defective sodium han-
type animals. Moreover, during dietary sodium restric- dling [17]. Our analysis of mice with combined deficiency
tion, the reduced blood pressure in COX-1-deficient of COX-1 and AT1A receptors indicates that during low
mice was associated with exaggerated natriuresis. This salt feeding, in the absence of AT1A receptors, COX-1
abnormal natriuresis was not due to impaired activation assumes a critical compensatory role. When this function
of the RAS, since renin expression and aldosterone pro- is absent, adaptation to sodium depletion is impaired
duction were appropriately stimulated by the sodium- further, resulting in volume depletion and severe hypo-
deficient diet and the absolute levels of renin mRNA tension that can be fatal. The COX and RAS are both
and aldosterone excretion were actually highest in the activated when effective arterial volume is reduced, as
COX-1/ animals. in fluid volume depletion, congestive heart failure, and
Our studies suggest that prostanoids produced by cirrhosis [8, 9]. In these circumstances, it has been sug-
COX-1 have non-redundant actions to regulate blood gested that enhanced production of prostanoids attenu-
pressure that are particularly important when dietary ates the vasoconstrictor and anti-natriuretic effects of
sodium intake is limited. Further, the absence of COX-1 angiotensin II [2]. Our data indicate that COX-1 has an
cannot be compensated for by the presence of COX-2 alternative function in these circumstances: to promote
in the COX-1/ mice. Since the enzymatic functions renal sodium retention and to support blood pressure.
of the two COX isoforms are virtually identical [5] and
because of the importance of the kidney in chronic blood ACKNOWLEDGMENTS
pressure regulation, the unique functions of COX-1 in
This work was supported by grants from the National Institute of
blood pressure homeostasis may be related to its distinct Health (DK-38103, HL-56122, and HL-49277) and the Research Ser-
vice of the Department of Veterans Affairs. We thank Ms. Jenniferpattern of expression in the kidney [20, 21]. Alterna-
Goulet and Ms. Beverly H. Koller from Department of Medicine,tively, discrete coupling between COX isoforms and syn-
University of North Carolina, Chapel Hill, North Carolina, who pro-
thesis of specific eicosanoid moieties has been suggested vided the COX-1-deficient mice used in this study.
in previous studies [29, 30, 32]. Because prostanoids often
Reprint requests to Thomas M. Coffman, M.D., Building 6/Nephrol-function in an autocrine/paracrine fashion, expression
ogy, VA Medical Center, 508 Fulton Street, Durham, North Carolina
and activity of COX-1 within specific nephron segments 27705, USA.
E-mail: tcoffman@acpub.duke.educould produce circumscribed, local physiological actions.
Athirakul et al: COX-1 in blood pressure homeostasis 2329
genase-1 and -2 in adult and fetal human kidney: Implication forREFERENCES
renal function. Am J Physiol 272(4 Pt 2):F460–F468, 1997
22. Vio CP, Cespedes C, Gallardo P, Masferrer JL: Renal identifi-1. Needleman P, Turk J, Jakschik BA, et al: Arachidonic acid metab-
cation of cyclooxygenase-2 in a subset of thick ascending limb cells.olism. Annu Rev Biochem 55:69–102, 1986
Hypertension 30(3 Pt 2):687–692, 19972. Nasjletti A: The role of eicosanoids in angiotensin-dependent
23. Harris RC, McKanna JA, Akai BY, et al: Cyclooxygenase-2 ishypertension. Hypertension 31(1 Pt 2):194–200, 1998
associated with the macula densa of rat kidney and increases with3. Anderson RJ, Berl T, McDonald KM, Schrier RW: Prostaglan-
salt restriction. J Clin Invest 94:2504–2510, 1994dins: Effects on blood pressure, renal blood flow, sodium and water
24. Jensen BL, Kurtz A: Differential regulation of renal cyclooxygen-excretion. Kidney Int 10:205–215, 1976
ase mRNA by dietary salt intake. Kidney Int 52:1242–1249, 19974. Breyer MD, Zhang Y, Guan Y, et al: Regulation of renal function
25. Harding P, Sigmon DH, Alfie ME, et al: Cyclooxygenase-2 medi-by prostaglandin E receptors. Kidney Int 54(Suppl 67):S88–S94, 1998
ates increased renal renin content induced by low-sodium diet.5. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxi- Hypertension 29(1 Pt 2):297–302, 1997dase H synthases (cyclooxygenase)-1 and -2. J Biol Chem 271: 26. Cheng HF, Wang JL, Zhang MZ, et al: Angiotensin II attenuates
33157–33160, 1996 renal cortical cyclooxygenase-2 expression. J Clin Invest 103:953–
6. O’Neill GP, Ford-Hutchinson AW: Expression of mRNA for 961, 1999
cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS 27. Dinchuk JE, Car BD, Focht RJ, et al: Renal abnormalities and an
Lett 330:156–160, 1993 altered inflammatory response in mice lacking cyclooxygenase II.
7. Mitchell JA, Akarasereenont P, Thiemermann C, et al: Selectiv- Nature 378:406–409, 1995
ity of nonsteroidal antiinflammatory drugs as inhibitors of constitu- 28. Morham SG, Langenbach R, Loftin CD, et al: Prostaglandin
tive and inducible cyclooxygenases. Proc Natl Acad Sci USA 90: synthase 2 gene disruption causes severe renal pathology in the
11693–11697, 1993 mouse. Cell 83:473–482, 1995
8. Scharschmidt L, Simonson M, Dunn MJ: Glomerular prostaglan- 29. McAdam BF, Catella-Lawson F, Mardini IA, et al: Systemic
dins, angiotensin II, and nonsteroidal anti-inflammatory drugs. Am biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The hu-
man pharmacology of a selective inhibitor of COX-2. Proc NatlJ Med 81:30–42, 1986
Acad Sci USA 96:272–277, 19999. Palmer BF, Henrich WL: Clinical acute renal failure with nonste-
30. Catella-Lawson F, McAdam B, Morrison BW, et al: Effects ofroidal anti-inflammatory drugs. Semin Nephrol 15:214–227, 1995
specific inhibition of cyclooxygenase-2 on sodium balance, hemo-10. Pope JE, Anderson JJ, Felson DT: A meta-analysis of the effects
dynamics and vasoactive eicosanoids. J Pharmacol Exp Ther 289:of nonsteroidal anti-inflammatory drugs on blood pressure. Arch
735–741, 1999Intern Med 153:477–484, 1993
31. Ito S, Carretero OA, Abe K, et al: Effect of prostanoids on renin11. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflam-
release from rabbit afferent arterioles with and without maculamatory drugs affect blood pressure? A meta-analysis. Ann Intern
densa. Kidney Int 35:1138–1144, 1989Med 121:289–300, 1994
32. Bustos M, Coffman TM, Saadi S, Platt JL: Modulation of eicosa-12. Langenbach R, Morham SG, Tiano HF, et al: Prostaglandin syn-
noid metabolism in endothelial cells in a xenograft model. Rolethase 1 gene disruption in mice reduces arachidonic acid-induced of cyclooxygenase-2. J Clin Invest 100:1150–1158, 1997inflammation and indomethacin-induced gastric ulceration. Cell 33. Sugimoto Y, Namba T, Shigemoto R, et al: Distinct cellular local-
83:483–492, 1995 ization of mRNAs for three subtypes of prostaglandin E receptor
13. Ito M, Oliverio MI, Mannon PJ, et al: Regulation of blood pres- in kidney. Am J Physiol 266(5 Pt 2):F823–F828, 1994
sure by the type 1A angiotensin II receptor gene. Proc Natl Acad 34. Breyer MD, Davis L, Jacobson HR, Breyer RM: Differential
Sci USA 92:3521–3525, 1995 localization of prostaglandin E receptor subtypes in human kidney.
14. Krege JH, Hodgin JB, Hagaman JR, Smithies O: A noninvasive Am J Physiol 270(5 Pt 2):F912–F918, 1996
computerized tail-cuff system for measuring blood pressure in 35. Morath R, Klein T, Seyberth HW, Nusing RM: Immunolocaliza-
mice. Hypertension 25:1111–1115, 1995 tion of four prostaglandin E2 receptor proteins EP1, EP2, EP3
15. Oliverio MI, Best CF, Kim HS, et al: Angiotensin II responses in and EP4 in human kidney. J Am Soc Nephrol 10:1851–1860, 1999
AT1A receptor-deficient mice: A role for AT1B receptors in blood 36. Mannon RB, Coffman TM, Mannon PJ: Distribution of binding
pressure regulation. Am J Physiol 272(4 Pt 2):F515–F520, 1997 sites for thromboxane A2 in the mouse kidney. Am J Physiol 271
(6 Pt 2):F1131–8, 199616. Burt DW, Mullins LJ, George H, et al: The nucleotide sequence
37. Welch WJ, Wilcox CS: Modulating role for thromboxane in tubu-of a mouse renin-encoding gene, Ren-1d, and its upstream region.
loglomerular feedback response in the rat. J Clin Invest 81:1843–Gene 84:91–104, 1989
1849, 198817. Oliverio MI, Best CF, Smithies O, Coffman TM: Regulation of
38. Schnermann J, Traynor T, Pohl H, et al: Vasoconstrictor re-sodium balance and blood pressure by the AT(1A) receptor for
sponses in thromboxane receptor knockout mice: Tubuloglomeru-angiotensin II. Hypertension 35:550–554, 2000
lar feedback and ureteral obstruction. Acta Physiol Scand 168:201–18. Coleman RA, Smith WL, Narumiya S: International Union of
207, 2000Pharmacology classification of prostanoid receptors: Properties,
39. Stock JL, Shinjo K, Burkhardt J, et al: The prostaglandin E2distribution and structure of the receptors and their subtypes. Phar- EP1 receptor mediates pain perception and regulates blood pres-
macol Rev 46:205–229, 1994 sure. J Clin Invest 107:325–331, 2000
19. Guyton AC, Coleman TG, Young DB, et al: Salt balance and 40. Tilley SL, Audoly LP, Hicks EH, et al: Reproductive failure and
long-term blood pressure control. Annu Rev Med 31:15–27, 1980 reduced blood pressure in mice lacking the EP2 prostaglandin E2
20. Yang T, Singh T, Pham H, et al: Regulation of cyclooxygenase receptor. J Clin Invest 103:1539–1545, 1999
expression in the kidney by dietary salt intake. Am J Physiol 274(3 41. Bonvalet JP, Pradelles P, Farman N: Segmental synthesis and
Pt 2):F481–F489, 1998 actions of prostaglandins along the nephron. Am J Physiol 253
21. Komhoff M, Grone HJ, Klein T, et al: Localization of cyclooxy- (3 Pt 2):F377–F387, 1987
